Literature DB >> 1401025

Bilophila wadsworthia bacteremia in two patients with hepatic abscesses.

M J Kasten1, J E Rosenblatt, D R Gustafson.   

Abstract

Bilophila wadsworthia, a recently described anaerobic gram-negative bacillus, was isolated from blood cultures of two patients with liver abscesses. These isolates exhibited the expected phenotypic characteristics, and identification was confirmed by cell wall fatty acid analysis by gas-liquid chromatography. This is the first documentation of bacteremia due to B. wadsworthia.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1401025      PMCID： PMC265535          DOI： 10.1128/jcm.30.9.2502-2503.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  4 in total

1.  Gas-liquid chromatographic analysis of cellular fatty acids for identification of gram-negative anaerobic bacilli.

Authors:  L Stoakes; T Kelly; B Schieven; D Harley; M Ramos; R Lannigan; D Groves; Z Hussain
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

2.  Bilophila wadsworthia, gen. nov. and sp. nov., a unique gram-negative anaerobic rod recovered from appendicitis specimens and human faeces.

Authors:  E J Baron; P Summanen; J Downes; M C Roberts; H Wexler; S M Finegold
Journal:  J Gen Microbiol       Date:  1989-12

3.  Permeability to beta-lactams in Bacteroides fragilis.

Authors:  G J Cuchural; S Hurlbut; M H Malamy; F P Tally
Journal:  J Antimicrob Chemother       Date:  1988-12       Impact factor: 5.790

4.  Properties of the penicillin-binding proteins of four species of the genus Bacteroides.

Authors:  L J Piddock; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191
  4 in total
  7 in total

1.  Antimicrobial susceptibility testing of Bilophila wadsworthia isolates submitted for routine laboratory examination.

Authors:  C Mochida; Y Hirakata; J Matsuda; F Iori; Y Ozaki; M Nakano; K Hamaguchi; K Izumikawa; T Yamaguchi; K Tomono; S Maesaki; Y Yamada; S Kohno; S Kamihira
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

2.  characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling.

Authors:  G B Rogers; M P Carroll; D J Serisier; P M Hockey; G Jones; K D Bruce
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

Review 3.  Clinical importance of Bilophila wadsworthia.

Authors:  S Finegold; P Summanen; S Hunt Gerardo; E Baron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

4.  Molecular identification of clinical "difficult-to-identify" microbes from sequencing 16S ribosomal DNA and internal transcribed spacer 2.

Authors:  Cancan Cheng; Jingjing Sun; Fen Zheng; Kuihai Wu; Yongyu Rui
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-01-03       Impact factor: 3.944

5.  Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice.

Authors:  Jane M Natividad; Bruno Lamas; Hang Phuong Pham; Marie-Laure Michel; Dominique Rainteau; Chantal Bridonneau; Gregory da Costa; Johan van Hylckama Vlieg; Bruno Sovran; Celia Chamignon; Julien Planchais; Mathias L Richard; Philippe Langella; Patrick Veiga; Harry Sokol
Journal:  Nat Commun       Date:  2018-07-18       Impact factor: 14.919

6.  Diversity and community pattern of sulfate-reducing bacteria in piglet gut.

Authors:  Shuwen Ran; Chunlong Mu; Weiyun Zhu
Journal:  J Anim Sci Biotechnol       Date:  2019-05-13

7.  Zinc inhibits lethal inflammatory shock by preventing microbe-induced interferon signature in intestinal epithelium.

Authors:  Jolien Souffriau; Steven Timmermans; Tineke Vanderhaeghen; Charlotte Wallaeys; Kelly Van Looveren; Lindsy Aelbrecht; Sylviane Dewaele; Jolien Vandewalle; Evy Goossens; Serge Verbanck; Filip Boyen; Melanie Eggermont; Lindsey De Commer; Riet De Rycke; Michiel De Bruyne; Raul Tito; Marlies Ballegeer; Sofie Vandevyver; Tiago Velho; Luis Ferreira Moita; Tino Hochepied; Karolien De Bosscher; Jeroen Raes; Filip Van Immerseel; Rudi Beyaert; Claude Libert
Journal:  EMBO Mol Med       Date:  2020-09-11       Impact factor: 12.137
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.